Summary
We describe a patient with essential thrombocythemia (ET) who developed multiple myeloma (MM) 5 years after the initial diagnosis. A review of the literature revealed no additional reports of the association of these two diseases. Development of MM was not related to treatment of essential thrombocythemia. This association suggests an alteration at the pluripotential stem cell level.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Belluci S, Janvier M, Tobelem G, et al. (1988) Essential thrombocythemia. Clinical, evolutionary and biological data. Cancer 58: 2440–2447
Durie BGM, Salmon SE (1985) Staging, kinetics, and flow cytometry of multiple myeloma. Neoplastic diseases of the blood. Churchill Livingstone, New York
Economopoulos T, Stathakis N, Papageorgiou E, et al. (1986) Myeloproliferative disorder during the course of multiple myeloma. Acta Haematol 76: 176–177
Economopoulus T, Economidou J, Papageorgiou E, et al. (1989) Monoclonal gammopathy in chronic myeloproliferative disorders. Blut 58: 7–9
Freih-Lahr D, Barton JC, Hoffman R, et al. (1984) Blastic transformation of essential thrombocythemia: dual expression of myelomonoblastic/megakaryoblastic phenotypes. Blood 63: 866–872
Gabrail NY, Martin TW (1991) Coexistence of essential thrombocythemia and chronic lymphocytic leukemia. Acta Haematol 85: 31–33
Gaetani GF, Ferraris AM, Galiano S, et al. (1982) Primary thrombocythemia: clonal origin of platelets, erythrocytes, and granulocytes in AGdB/Gd Mediterranean subject. Blood 59: 76–79
Greenberg BR, Miller C, Cardiff RD, et al. (1983) Concurrent development of proleukemic, lympho-proliferative and plasma cell disorders. Br J Haematol 53: 125–133
Gris JC, Schved JF, Arnaud A, et al. (1989) Myelodisplastic syndrome and secondary acute leukemia after treatment of essential thrombocythemia with melphalan (letter). Am J Hematol 30: 47
Hehlmann R, Jahn M, Baumann B, Köpcke W (1988) Essential thrombocythemia. Clinical characteristics and course of 61 patients. Cancer 61: 2487–2496
Lewis SM, Szur L, Hoffbrand AV (1978) Thrombocythemia. Clin Haematol 1: 319
Manoharan A, Catovsky D, Clein P, et al. (1981) Simultaneous or spontaneous occurrence of lympho- and myeloproliferative disorders. A report of four cases. Br J Haematol 48: 111–116
Murphy S, Iland H, Rosenthal D, Laszlo J (1986) Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group. Semin Hematol 23: 177–182
Nagura E, Kawashima K, Yamada K (1985) Multiple primary cancers associated with hematological malignancies. Jpn J Clin Oncol 15 [Suppl 1]: 211
Raskind WH, Jacobson R, Murphy S, et al. (1985) Evidence for the involvement of B lymphoid cells in polycythemia vera and essential thrombocythemia. J Clin Invest 75: 1388
Rondeau E, Solal-Celigny P, Dhermy D, et al. (1983) Immune disorders in agnogenic myeloid metaplasia: relation to myelofibrosis. Br J Haematol 53: 467–475
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Prósper, F., Borbolla, J.R., Rifón, J. et al. Coexistence of essential thrombocythemia and multiple myeloma. Ann Hematol 65, 103–105 (1992). https://doi.org/10.1007/BF01698139
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01698139